What is Tirzepatide?
Tirzepatide is an injection to help control Type 2 diabetes mellitus in adults. It is an aid to diet and exercise to improve glycemic control.
Tirzepatide further reduces HbA1C compared to Semaglutide by an additional 24%.
What conditions can it improve?
Tirzepatide can improve Type 2 diabetes blood sugar levels and promote weight loss.
After 40 weeks of using Tirzepatide, (on all doses), it surpassed Semaglutide in weight loss from a range of 15 lbs. to 25 lbs.
Weight loss with Tirzepatide offers at least 30%, 60%, and up to 95% more weight loss vs. Semaglutide 1 mg.
What are the benefits of Tirzepatide?
Semaglutide injections at Fort Wayne Integrative Medicine offer many advantages for weight loss and can help improve patients’ overall health. In clinical trials, Semaglutide injections showed an average loss of 12-18% of people’s initial body weight after 56 weeks*.
Obesity and long-term weight loss are difficult due to underlying systemic inflammation.
Tirzepatide is a body protection peptide that can address components of the underlying inflammation with the hope of more sustained weight loss and better health.
Who’s a good candidate?
Patients who’ve had little to no success in weight loss. Type 2 diabetes patients will also experience the benefits of Tirzepatide by helping manage their blood sugar levels and in turn lose weight.*
- Type 2 diabetes
- Weight loss
- Controls high blood sugar
- Increases energy expenditure
*Individual results may vary